We bring you the latest news from the healthcare about the health care in the United Kingdom. Do your have news for us? Contact the editor. Watch also this special movie.

dinsdag 1 augustus 2017

Nature Reviews Urology - Table of Contents alert Volume 14 Issue 8

If you are unable to see the message below, click here to view.

Nature Reviews Urology

 
TABLE OF CONTENTS
 
August 2017 Volume 14 Number 8
Nature Reviews Urology cover
2016 2-year Impact Factor 7.735
Journal Metrics 2-year Median 5
In this issue
Research Highlights
News and Views
Reviews

Also this month
 Featured article:
Prostate cancer: Better VISTAs ahead? Potential and pitfalls of immunotherapy
Ravi A. Madan and James L. Gulley


Subscribe
 
Facebook
 
RSS
 
Recommend to library
 
Twitter
 
RESEARCH HIGHLIGHTS
Top

Infection: Impeding UPEC gut colonization
Published online: 20 June 2017
p449 | doi:10.1038/nrurol.2017.99

PDF


Prostate cancer: Lineage predicts ADT response
Published online: 31 May 2017
p450 | doi:10.1038/nrurol.2017.80

PDF


Prostate cancer: Escaping enzalutamide: Malat1 contributes to resistance
Published online: 06 June 2017
p450 | doi:10.1038/nrurol.2017.91

PDF


Kidney cancer: New autochthonous ccRCC model
Published online: 13 June 2017
p451 | doi:10.1038/nrurol.2017.92

PDF


Male factor infertility: Piwi, Hiwi, Miwi: essential genes for effective spermiogenesis
Published online: 13 June 2017
p451 | doi:10.1038/nrurol.2017.95

PDF


Prostate cancer: Epigenetic AR regulation
Published online: 04 July 2017
p452 | doi:10.1038/nrurol.2017.110

PDF


Surgery: First penis transplant in the USA
Published online: 06 June 2017
p452 | doi:10.1038/nrurol.2017.88

PDF


Kidney cancer: Methylation of obesity-related genes is associated with prognosis
Published online: 13 June 2017
p452 | doi:10.1038/nrurol.2017.94

PDF


Kidney cancer: Diving into the genome of papillary RCC unearths therapeutic pearls
Published online: 20 June 2017
p453 | doi:10.1038/nrurol.2017.100

PDF


Kidney cancer: FBV indicates sunitinib response
Published online: 20 June 2017
p453 | doi:10.1038/nrurol.2017.101

PDF


Prostate cancer: ETS factors in the balance
Published online: 27 June 2017
p454 | doi:10.1038/nrurol.2017.103

PDF


Prostate cancer: Mechanisms of cancer metabolism: mTORC1 mediates AMD1
Published online: 04 July 2017
p454 | doi:10.1038/nrurol.2017.111

PDF


Nature Reviews Urology
JOBS of the week
Post-graduate researcher
Mosaiques Diagnostics GmbH
Postdoctoral Fellowship
Cleveland Clinic, Cleveland, OH
More Science jobs from
Nature Reviews Urology
EVENT
International Colloquium on Medical, Pharma & Drug Studies
29.11.17
Brisbane, Australia
More science events from
 
NEWS AND VIEWS
Top
Prostate cancer: Better VISTAs ahead? Potential and pitfalls of immunotherapy
Ravi A. Madan & James L. Gulley
Published online: 23 May 2017
p455 | doi:10.1038/nrurol.2017.75
Despite a rapid increase in the use of anticancer immunotherapy, our understanding of the mechanisms of action and the patients' responses remains limited. The discovery of immune inhibitory markers in the tumour microenvironment following immunotherapy should improve our understanding and might enable us to better apply combination therapies.
Full Text | PDF

Prostate cancer: Draft USPSTF 2017 recommendation on PSA testing — a sea-change?
Theodorus H. Van der Kwast & Monique J. Roobol
Published online: 13 June 2017
p457 | doi:10.1038/nrurol.2017.89
Increased evidence that prostate-cancer-specific mortality can be reduced using serum PSA screening, in addition to the increasing role of active surveillance in reducing overtreatment underlies the revised USPSTF recommendation, which now supports selective use of PSA testing. However, this recommendation should not be interpreted as a license to return to the unthinking use of PSA testing of men between 50 to 70 years of age.
Full Text | PDF

 
REVIEWS
Top
Current clinical scoring systems of percutaneous nephrolithotomy outcomes
Wayland J. Wu & Zeph Okeke
Published online: 23 May 2017
p459 | doi:10.1038/nrurol.2017.71
Wu and Okeke review studies of the major validated scoring systems for outcomes of percutaneous nephrolithotomy, highlighting their performance in predicting stone-free rates and complications. They discuss the advantages and disadvantages of each system, provide suggestions for their applicability and propose requirements for a future unified scoring system.
Abstract | Full Text | PDF

Oxidative stress and male infertility
Shilpa Bisht, Muneeb Faiq, Madhuri Tolahunase & Rima Dada
Published online: 16 May 2017
p470 | doi:10.1038/nrurol.2017.69
High levels of seminal oxidative stress lead to sperm DNA damage and male factor infertility. In this review, the authors describe the mechanisms of oxidative-stress-induced male factor infertility, and how lifestyle-related interventions might reduce levels of seminal oxidative stress, ameliorate infertility and potentially improve the health of the children of men with high levels of seminal oxidative stress.
Abstract | Full Text | PDF

An overview of female-to-male gender-confirming surgery
Shane D. Morrison, Mang L. Chen & Curtis N. Crane
Published online: 16 May 2017
p486 | doi:10.1038/nrurol.2017.64
Gender transition can substantially improve quality-of-life in individuals with gender dysphoria, and various surgical options are available for female-to-male (FtM) transition, including facial and chest masculinization, body contouring, and genital surgery. In this Review, the authors describe the management of these patients, with a particular emphasis on the surgical techniques used, and consider developments that might improve outcomes for FtM patients in the future.
Abstract | Full Text | PDF

Personalized peptide vaccines and their relation to other therapies in urological cancer
Takahiro Kimura, Shin Egawa & Hirotsugu Uemura
Published online: 31 May 2017
p501 | doi:10.1038/nrurol.2017.77
Kimura and colleagues describe the scientific background to the concept of personalized peptide vaccines and review clinical data on safety and efficacy of these treatments for urological cancers. They also provide a perspective on the future of peptide vaccines in urology.
Abstract | Full Text | PDF

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events
*Nature Reviews Urology was previously published as Nature Clinical Practice Urology.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount
(You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department

For print subscription enquiries, please contact our subscription department

For other enquiries, please contact our feedback department

Springer Nature | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature